Stockero KJ - Search Results

1

Metaphase cells with normal G-bands have cryptic interstitial deletions in 13q14 detectable by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia.

Stockero KJ, Fink SR, Smoley SA, Paternoster SF, Shanafelt TD, Call TG, Zent CS, Van Dyke DL, Kay NE, Dewald GW. Stockero KJ, et al. Cancer Genet Cytogenet. 2006 Apr 15;166(2):152-6. doi: 10.1016/j.cancergencyto.2005.10.011. Cancer Genet Cytogenet. 2006. PMID: 16631472

2

Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia.

Nowakowski GS, Dewald GW, Hoyer JD, Paternoster SF, Stockero KJ, Fink SR, Smoley SA, Remstein ED, Phyliky RL, Call TG, Shanafelt TD, Kay NE, Zent CS. Nowakowski GS, et al. Among authors: stockero kj. Br J Haematol. 2005 Jul;130(1):36-42. doi: 10.1111/j.1365-2141.2005.05548.x. Br J Haematol. 2005. PMID: 15982342 Free article.

3

Preclinical validation of fluorescence in situ hybridization assays for clinical practice.

Wiktor AE, Van Dyke DL, Stupca PJ, Ketterling RP, Thorland EC, Shearer BM, Fink SR, Stockero KJ, Majorowicz JR, Dewald GW. Wiktor AE, et al. Among authors: stockero kj. Genet Med. 2006 Jan;8(1):16-23. doi: 10.1097/01.gim.0000195645.00446.61. Genet Med. 2006. PMID: 16418595 Free article.

4

Loss of TP53 is due to rearrangements involving chromosome region 17p10 approximately p12 in chronic lymphocytic leukemia.

Fink SR, Smoley SA, Stockero KJ, Paternoster SF, Thorland EC, Van Dyke DL, Shanafelt TD, Zent CS, Call TG, Kay NE, Dewald GW. Fink SR, et al. Among authors: stockero kj. Cancer Genet Cytogenet. 2006 Jun;167(2):177-81. doi: 10.1016/j.cancergencyto.2006.01.005. Cancer Genet Cytogenet. 2006. PMID: 16737921

5

Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia.

Shanafelt TD, Witzig TE, Fink SR, Jenkins RB, Paternoster SF, Smoley SA, Stockero KJ, Nast DM, Flynn HC, Tschumper RC, Geyer S, Zent CS, Call TG, Jelinek DF, Kay NE, Dewald GW. Shanafelt TD, et al. Among authors: stockero kj. J Clin Oncol. 2006 Oct 1;24(28):4634-41. doi: 10.1200/JCO.2006.06.9492. J Clin Oncol. 2006. PMID: 17008705

6

Efficacy of conventional cytogenetics and FISH for EGR1 to detect deletion 5q in hematological disorders and to assess response to treatment with Lenalidomide.

Zou YS, Fink SR, Stockero KJ, Paternoster SF, Smoley SA, Tun HW, Reeder CB, Tefferi A, Dewald GW. Zou YS, et al. Among authors: stockero kj. Leuk Res. 2007 Sep;31(9):1185-9. doi: 10.1016/j.leukres.2006.10.011. Epub 2006 Nov 27. Leuk Res. 2007. PMID: 17125835

7

Frequency, hematopathology, and detection of a new isodicentric variant of deletion 20q.

Smoley SA, Fink SR, Paternoster SF, Stockero KJ, Nguyen LP, Nguyen PL, Hanson CA, Dewald GW. Smoley SA, et al. Among authors: stockero kj. Cancer Genet Cytogenet. 2007 Mar;173(2):144-9. doi: 10.1016/j.cancergencyto.2006.11.003. Cancer Genet Cytogenet. 2007. PMID: 17321330

8

Familial 22q11.2 deletions in DiGeorge/velocardiofacial syndrome are predominantly smaller than the commonly observed 3Mb.

Adeyinka A, Stockero KJ, Flynn HC, Lorentz CP, Ketterling RP, Jalal SM. Adeyinka A, et al. Among authors: stockero kj. Genet Med. 2004 Nov-Dec;6(6):517-20. doi: 10.1097/01.gim.0000144011.97407.b6. Genet Med. 2004. PMID: 15545748

9

JAK2(V617F) mutation in myelodysplastic syndrome (MDS) with del(5q) arises in genetically discordant clones.

Sokol L, Caceres G, Rocha K, Stockero KJ, Dewald DW, List AF. Sokol L, et al. Among authors: stockero kj. Leuk Res. 2010 Jun;34(6):821-3. doi: 10.1016/j.leukres.2009.09.016. Epub 2009 Oct 9. Leuk Res. 2010. PMID: 19819015

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page